+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Anti-Infectives - Global Strategic Business Report - Product Thumbnail Image

Anti-Infectives - Global Strategic Business Report

  • Report
  • January 2026
  • 158 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease (COPD) Treatment - Global Strategic Business Report - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease (COPD) Treatment - Global Strategic Business Report

  • Report
  • January 2026
  • 299 Pages
  • Global
From
Anemia Drugs - Global Strategic Business Report - Product Thumbnail Image

Anemia Drugs - Global Strategic Business Report

  • Report
  • January 2026
  • 383 Pages
  • Global
From
Huntington's Disease Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Huntington's Disease Therapeutics - Global Strategic Business Report

  • Report
  • January 2026
  • 172 Pages
  • Global
From
Inflammatory Bowel Disease (IBD) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Inflammatory Bowel Disease (IBD) Therapeutics - Global Strategic Business Report

  • Report
  • January 2026
  • 504 Pages
  • Global
From
Multiple Sclerosis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Multiple Sclerosis Therapeutics - Global Strategic Business Report

  • Report
  • January 2026
  • 268 Pages
  • Global
From
Neurodegenerative Drugs Market - Global Strategic Business Report - Product Thumbnail Image

Neurodegenerative Drugs Market - Global Strategic Business Report

  • Report
  • January 2026
  • 376 Pages
  • Global
From
Tuberculosis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Tuberculosis Therapeutics - Global Strategic Business Report

  • Report
  • January 2026
  • 283 Pages
  • Global
From
Acute Coronary Syndrome - Global Strategic Business Report - Product Thumbnail Image

Acute Coronary Syndrome - Global Strategic Business Report

  • Report
  • January 2026
  • 158 Pages
  • Global
From
Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics - Global Strategic Business Report

  • Report
  • January 2026
  • 186 Pages
  • Global
From
Bipolar Disorder Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Bipolar Disorder Therapeutics - Global Strategic Business Report

  • Report
  • January 2026
  • 380 Pages
  • Global
From
Cystic Fibrosis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Cystic Fibrosis Therapeutics - Global Strategic Business Report

  • Report
  • January 2026
  • 282 Pages
  • Global
From
Diabetic Retinopathy Treatment - Global Strategic Business Report - Product Thumbnail Image

Diabetic Retinopathy Treatment - Global Strategic Business Report

  • Report
  • January 2026
  • 273 Pages
  • Global
From
Intravenous (IV) Iron Drugs - Global Strategic Business Report - Product Thumbnail Image

Intravenous (IV) Iron Drugs - Global Strategic Business Report

  • Report
  • January 2026
  • 354 Pages
  • Global
From
Tinea Pedis (Athlete's Foot) Treatment - Global Strategic Business Report - Product Thumbnail Image

Tinea Pedis (Athlete's Foot) Treatment - Global Strategic Business Report

  • Report
  • January 2026
  • 284 Pages
  • Global
From
Narcolepsy Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Narcolepsy Therapeutics - Global Strategic Business Report

  • Report
  • January 2026
  • 363 Pages
  • Global
From
Endometriosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Endometriosis Drugs - Global Strategic Business Report

  • Report
  • January 2026
  • 191 Pages
  • Global
From
Pediatric Drugs and Vaccines - Global Strategic Business Report - Product Thumbnail Image

Pediatric Drugs and Vaccines - Global Strategic Business Report

  • Report
  • January 2026
  • 292 Pages
  • Global
From
Overactive Bladder (OAB) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Overactive Bladder (OAB) Therapeutics - Global Strategic Business Report

  • Report
  • January 2026
  • 271 Pages
  • Global
From
Sepsis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Sepsis Therapeutics - Global Strategic Business Report

  • Report
  • January 2026
  • 291 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more